Skip to main content

Find Clinical Trials

Home
Conditions
Salivary Gland Neoplasms

Clinical trial condition

Salivary Gland Neoplasms

Explore clinical trials studying Salivary Gland Neoplasms. Study availability and eligibility vary by location and protocol.

191 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Salivary Gland Neoplasms trial results

Completed

Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel

NCT00003569

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +40 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

NCT00028496

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck

NCT00077428

Conditions: Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +12 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

NCT00828516

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +33 more
Locations: Lynda Jackson Macmillan Centre at Mount Vernon Cancer Centre Northwood, United Kingdom

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

NCT00068497

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +132 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

NCT00899821

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations: Not specified

View Trial Details

Completed

NGR-TNF in Treating Patients With Advanced Solid Tumors

NCT00098943

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +60 more
Locations: University Medical Center Hamburg - Eppendorf Hamburg, Germany

Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands

View Trial Details

Completed

Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck

NCT00017498

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Mouth Diseases, +6 more
Locations: Institut Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Ospedale Santa Croce Cuneo, Italy

View Trial Details

Completed

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00639769

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations: Central Georgia Hematology Oncology Associates, P.C. Macon, Georgia, United States

Erlanger Health System Chattanooga, Tennessee, United States

Jackson-Madison County Hospital Jackson, Tennessee, United States

East Tennessee State University Johnson City, Tennessee, United States

View Trial Details